CTOs on the Move

Inspire Pharma

www.inspirepharm.com

 
Inspire is a biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Clinsys Clinical Research

Clinsys Clinical Research is a Bedminster, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The CDM Group

The CDM Group is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. The CDM Group is based in New York, NY. You can find more information on The CDM Group at www.thecdmgroup.com

Neighborhood Health Plan

Neighborhood Health Plan is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Greenway Medical Technologies, Inc.

Greenway Medical Technologies provides the latest in ambulatory healthcare business solutions and services to 20000 healthcare providers and professionals nationwide, in 30 specialties and subspecialties, by enhancing the delivery of patient care

Berg LLC

BERG is a Boston-based biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform. This platform combines patient biology and AI-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. For patients this means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. BERG has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials. BERG is committed to improving the lives of patients through precision medicine made possible by our innovative platforms.